Table 2 from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Authors:Alberto A. Gabizon, Hadar Goldvaser, Adar Yaacov et al.
Comparative Performance of Frontier Large Language Models for Extracting High-Risk Pathologic Features from Unstructured Gastrointestinal Oncology Reports: A Systematic Benchmarking Study with Human and Traditional NLP Baselines
Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Alberto A. Gabizon, Hadar Goldvaser et al. - Unknown